Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 3,519 Shares

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 3,519 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $30.06, for a total transaction of $105,781.14. Following the completion of the sale, the chief operating officer now directly owns 741,197 shares of the company’s stock, valued at approximately $22,280,381.82. This trade represents a 0.47 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Evan Roberts also recently made the following trade(s):

• On Thursday, February 13th, Evan Roberts sold 16,005 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total value of $480,150.00.
• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total transaction of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total transaction of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $76,450.53.

Phreesia Stock Down 4.0 %

Shares of NYSE:PHR opened at $28.49 on Friday. The business’s 50 day moving average is $27.22 and its 200 day moving average is $23.80. The stock has a market cap of $1.66 billion, a P/E ratio of -19.38 and a beta of 0.96. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.58) EPS. Sell-side analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Institutional Investors Weigh In On Phreesia

A number of hedge funds have recently made changes to their positions in the stock. International Assets Investment Management LLC lifted its position in shares of Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after buying an additional 1,395 shares during the last quarter. Arcadia Investment Management Corp MI increased its position in shares of Phreesia by 9.5% during the third quarter. Arcadia Investment Management Corp MI now owns 97,085 shares of the company’s stock worth $2,213,000 after purchasing an additional 8,460 shares in the last quarter. TimesSquare Capital Management LLC boosted its position in shares of Phreesia by 2.3% in the 3rd quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock worth $19,791,000 after purchasing an additional 19,395 shares in the last quarter. Versor Investments LP acquired a new position in Phreesia during the 3rd quarter valued at about $694,000. Finally, GSA Capital Partners LLP boosted its holdings in Phreesia by 418.3% in the third quarter. GSA Capital Partners LLP now owns 49,553 shares of the company’s stock worth $1,129,000 after acquiring an additional 39,993 shares in the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

PHR has been the topic of several analyst reports. Needham & Company LLC reissued a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research note on Friday, January 10th. JMP Securities restated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. KeyCorp lifted their price objective on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Piper Sandler reissued an “overweight” rating and issued a $33.00 target price (up previously from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Finally, Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and lifted their price target for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Thirteen research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $31.15.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.